AHMAD MEHDI: Open Payments
NPI 1427037159 · TULLY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 15 payments from 7 companies in 2025. Trend: 2023 $400 · 2024 $286 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $127 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Seqirus USA Inc | 1 | $28 |
| Lilly USA, LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, Fluad, FARXIGA, MOUNJARO, ZORYVE, Korlym, UZEDY.
Industry payments across NY — which companies pay providers there.
